VYOME HOLDINGS, INC. Net Cash Provided by (Used in) Investing Activities, Continuing Operations
VYOME HOLDINGS, INC. (HIND) reported Net Cash Provided by (Used in) Investing Activities, Continuing Operations of -$3.01 million for the 9-month period ending 2016-09-30, per its 10-Q filed 2016-11-10.
Discontinued › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations · last filed 2016-11-10
- 2016-09-30: Net Cash Provided by (Used in) Investing Activities, Continuing Operations 9 month -$3.01M.
- 2015-09-30: Net Cash Provided by (Used in) Investing Activities, Continuing Operations 9 month -$3.12M.
| Period end | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 9 month |
|---|---|
| 2016-09-30 | -$3.01M 10-Q · filed 2016-11-10 |
| 2015-09-30 | -$3.12M 10-Q · filed 2016-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |